Amphinex

Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.

It has had promising preliminary results in early trials on patients with advanced head and neck cancer[1] [2] [3]

References
  1. "Successful completion of the third dose group in the Amphinex study. Continued good tolerability and strong tumour response is reported, with an apparent high treatment specificity for cancer cells. | PCI Biotech". Archived from the original on 2011-07-24. Retrieved 2010-04-06. Successful completion of the third dose group in the Amphinex study. March 2010
  2. http://www.medicalnewstoday.com/articles/176431.php PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial. Jan 2010
  3. "Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.